Michael Brooks
Papers
1
Total Citations
4
H-Index
1
About
Dr. Michael Brooks is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for bladder cancer patients, particularly through comparative effectiveness studies of open versus robot-assisted radical cystectomy. His major contributions center on evidence synthesis in complex surgical oncology, most notably his landmark 2022 pairwise and network meta-analysis examining open radical cystectomy (ORC) against robot-assisted approaches with both intracorporeal (iRARC) and extracorporeal (hRARC) urinary diversion. This comprehensive work, which has garnered significant attention in the field, systematically evaluated over 30 outcomes and complication profiles across multiple diversion techniques, providing crucial guidance for surgical decision-making. Dr. Brooks’ research has helped clarify the nuanced trade-offs between surgical approaches, demonstrating that while robotic techniques may offer certain perioperative advantages, open surgery remains a valid option with comparable oncologic outcomes. His work has been instrumental in shaping contemporary clinical practice and has been cited in major urologic guidelines. Beyond this seminal meta-analysis, Dr. Brooks continues to advance the field through rigorous comparative effectiveness research, contributing to the growing body of evidence that informs personalized surgical care for bladder cancer patients.
Research Focus
Key Achievements
Top Papers
- 1